Company
EnzyTag
Traceless Ligation
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Our technology offers an entry into linear and cyclic peptide drugs, small proteins, (bio)conjugates, Antibody Drug Conjugates, PROTACs and LYTACs.
Loading relationship preview